“Systemic Juvenile Idiopathic Arthritis (SJIA)-Pipeline Insights, 2015”- A DelveInsight’s Report

NEW DELHI - July 22, 2015 - PRLog -- The Indication pipeline Insight Reports provides client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

· R&D activities and technologies used along with the pipeline molecules in development.

· Information related to collaborations, in-licensing and out-licensing deals.

· Stages of development of pipeline molecules.

· Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

The ”SJIA -Pipeline Insights” Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecule. Therefore DelveInsight’s report on SJIA helps to optimize portfolio by creating effective counter-strategies to gain competitive and therapeutic advantage in global Pharma market. In addition, it assesses the major market drivers and barriers in development of Pipeline molecules which helps to understand market for collaborations and licensing deals.

DelveInsight is offering the Report at a price of USD 1250 as a single user license, US 2500 as a site license and USD 400 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email at info@delveInsight.com

Keywords

DelveInsight, Indication Pipeline Insight report, collaborations, licensing

Contact Us:

DelveInsight Business Research

New Delhi-110075, India

Phone: +91-11-45689769, +91 9650213330

Website: http://delveinsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm.  We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.